Intas Cefpet CLV 325mg Potentiated 3rd-Generation Cephalosporin Antibiotic Tablets for Dogs & Cats (Cefpodoxime Proxetil 200mg + Potassium Clavulanate 125mg) – Strip of 10 Tablets

Select Variant: 1

Description

Overcome multi-drug resistant bacterial pathogens, resolve complicated deep pyoderma, and safeguard surgical recovery with Intas Cefpet CLV 325mg Tablets (Strip of 10), available online at PetMitra. In small animal clinical practice, persistent or recurrent bacterial infections frequently fail standard antibiotic therapy. Pathogenic bacteria—most notably beta-lactamase-producing Staphylococcus pseudintermedius, Escherichia coli, and Klebsiella species—produce defense enzymes (beta-lactamases) that hydrolyze and deactivate the beta-lactam ring of standard penicillins and conventional cephalosporins. When standard treatments stall, continuing single-agent antibiotics risks therapeutic failure and chronic tissue damage. Intas Cefpet CLV 325mg overcomes enzymatic bacterial resistance through a synergistic, dual-action antimicrobial matrix: Advanced Cell-Wall Lysis (Cefpodoxime Proxetil 200mg): An orally bioavailable third-generation cephalosporin prodrug that metabolizes in vivo into active cefpodoxime. It binds to bacterial penicillin-binding proteins (PBPs), halting peptidoglycan cell wall cross-linking and triggering rapid autolytic enzyme activation to kill dividing pathogens. Irreversible Beta-Lactamase Suicide Inhibition (Clavulanic Acid 125mg): Potassium clavulanate acts as a potent, irreversible "suicide inhibitor" of bacterial beta-lactamase enzymes. By permanently binding and neutralizing these destructive enzymes, clavulanate shields the cefpodoxime molecule from enzymatic degradation, restoring and broadening its bactericidal potency against resistant pathogens. Expanded Aerobic & Anaerobic Spectrum: Delivers bactericidal clearance against challenging Gram-positive cutaneous cocci (Staphylococcus pseudintermedius, Streptococcus spp.) as well as stubborn Gram-negative uropathogens and enteric bacteria (E. coli, Proteus mirabilis, Klebsiella pneumoniae, Pasteurella multocida). Deep Tissue Penetration & Perioperative Defense: Rapidly reaches therapeutic concentrations in deep dermal layers, subcutaneous tissues, bronchial secretions, and urinary tract epithelium. It is widely prescribed for perioperative prophylaxis during orthopedic and major soft-tissue surgeries. Convenient Once-Daily Dosing (SID): Maintains sustained bactericidal concentrations above the minimum inhibitory concentration (MIC) over 24 hours, simplifying dosing schedules and improving compliance compared to multi-dose regimens. Dual-Species Clinical Application: Validated and well-tolerated in canine and feline patients under direct veterinary prescription.